September 30 @ 4:00 pm - 5:30 pm Essential Insights Gained on Emicizumab – Navigating Surgery and Comorbidities
October 28 @ 4:00 pm - 5:30 pm Bispecific Antibodies: Redefining Relapse/Refractory Treatment in Follicular Lymphoma